Khartis Therapeutics Secures $50 Million in Latest Series B Funding Round

Khartis Therapeutics secured $50 million in its latest Series B, adding another data point to the Healthcare & Life Sciences funding market.

Khartis Therapeutics Raises $50 million in Funding

Khartis Therapeutics Raises $50 Million Series B, Bringing Total Funding To $95 Million.

Investors Behind the Funding

The round was backed by The Readout Manage alerts for this article Email this article Share this article Scott Olson/Getty Images By Meghana Keshavan Aug. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Khartis Therapeutics operates in Healthcare & Life Sciences. Khartis Therapeutics's financing adds to recent private-market activity.

Strategic Use of Funds

Stay on top of the science and politics driving biotech today?

Looking Ahead

Khartis Therapeutics Raises $50 Million Series B, Bringing Total Funding To $95 Million

Source reference: original announcement/article.